| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/01/2006 | US7084256 Plant extract; folded polypeptide |
| 08/01/2006 | US7084255 PRO1278 polypeptides |
| 08/01/2006 | US7084242 For therapy of human subject diagnosed for predisposition for increased serum cholesterol or LDL cholesterol |
| 08/01/2006 | US7084239 stimulates cancer antigen specific cytotoxic T lymphocytes; useful in cancer diagnostics and immunotherapeutics including a cancer vaccine. |
| 08/01/2006 | US7083986 Acridinium compound for use in the concurrent detection of target analytes in immunoassays or nucleic acid assays |
| 08/01/2006 | US7083965 Polypeptides, polynucleotides; hybrids; culture product |
| 08/01/2006 | US7083957 Modified proteins, designer toxins, and methods of making thereof |
| 08/01/2006 | US7083950 Isolated nucleic acids; binding to immunoglobulins |
| 08/01/2006 | US7083943 Polynucleotides related to murine anti-idiotype antibody 11D10 and methods of use thereof |
| 08/01/2006 | US7083940 Polynucleotide encoding a polypeptide which has proteolytic activity for insulin like growth factor binding protein; use in diagnosis of fetal abnormalities |
| 08/01/2006 | US7083934 Method for detecting transferrin receptor-like proteins |
| 08/01/2006 | US7083930 administering proteins or polypeptides for prophylaxis or diagnosis of nervous system and gastrointerstinal disorders ; genetic engineering; drug screening |
| 08/01/2006 | US7083927 Comprises nucleotide sequences coding ubiquitin protein ligase complex polypeptides for diagnosid and treatment of cancer, immune/inflammatory and neurological disorders |
| 08/01/2006 | US7083792 Immunologically active proteins from Borrelia burgdorferi |
| 08/01/2006 | US7083791 Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides |
| 08/01/2006 | US7083788 Modulators of the function of receptors of the TNF/NGF receptor family and other proteins |
| 08/01/2006 | US7083786 Mannan binding lectin-associated serine protease-2; serine protease that acts in the MBLectin complement fixation pathway |
| 08/01/2006 | US7083785 Tumor necrosis factor family and its blocking agent |
| 08/01/2006 | US7083784 Molecules with extended half-lives, compositions and uses thereof |
| 08/01/2006 | CA2265485C Small and intermediate conductance, calcium-activated potassium channels and uses thereof |
| 07/27/2006 | WO2006078746A2 Method, compositions and classification for tumor diagnostics and treatment |
| 07/27/2006 | WO2006078307A1 Fixed dosing of her antibodies |
| 07/27/2006 | WO2006078268A2 A peptide that elicits neutralizing antibodies targeting the hiv co-receptor, ccr5 |
| 07/27/2006 | WO2006078034A1 Cells capable of differentiating into cardiac muscle cells |
| 07/27/2006 | WO2006077874A1 Polymorphism of gene encoding drug metabolizing enzyme in monkey and the use thereof |
| 07/27/2006 | WO2006077873A1 Novel drug metabolizing enzyme in monkey and nucleic acid encoding the same |
| 07/27/2006 | WO2006077704A1 Method of screening for cancer and adenoma |
| 07/27/2006 | WO2006077442A2 Inhibition of islet amyloid polypeptide (iapp) aggregation for the treatment of type 2 diabetes |
| 07/27/2006 | WO2006077441A1 Specific binding members for ngf |
| 07/27/2006 | WO2006077152A2 Hla fusion molecules and uses thereof |
| 07/27/2006 | WO2006077101A2 Ager-peptides and use thereof |
| 07/27/2006 | WO2006050041A3 Methods for reducing or inhibiting brain inflammation or for promoting neurogenesis |
| 07/27/2006 | WO2006031912A3 Busulfan immunoassay |
| 07/27/2006 | WO2006031363A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 07/27/2006 | WO2006029275A3 Methods of using death receptor ligands and cd20 antibodies |
| 07/27/2006 | WO2006023491A3 Method of delivering rna interference and uses thereof |
| 07/27/2006 | WO2006015373A3 Antibodies to dkk-1 |
| 07/27/2006 | WO2006014798A3 Methods and compositions for using sax2 |
| 07/27/2006 | WO2006008076A3 Methods and agents stimulating the immune response |
| 07/27/2006 | WO2005111078A3 Anti-cea scfv-beta-lactamase contructs (cab molecules) in adept |
| 07/27/2006 | WO2005110459A3 Method of inducing immunity against stratum corneum chymotrytic enzyme |
| 07/27/2006 | WO2005097187A3 Methods of preventing uvb-induced skin damage |
| 07/27/2006 | WO2005070020A3 Gefitinib sensitivity-related gene expression and products and methods related thereto |
| 07/27/2006 | WO2005062979A3 Immunoassays, haptens, immunogens and antibodies for anti-hiv therapeutics |
| 07/27/2006 | WO2005060675A3 Novel spliced 5-ht1a receptors and methods, kits, and uses relating thereto |
| 07/27/2006 | WO2004058184A3 Anti-ngf antibodies and methods using same |
| 07/27/2006 | WO2004034988A3 Human anti-ifn-ϝ neutralizing antibodies as selective ifn-ϝ pathway inhibitors |
| 07/27/2006 | WO2003085086A3 Motif-grafted hybrid polypeptides and uses thereof |
| 07/27/2006 | US20060168691 Plants which synthesize a modified starch, process for the production thereof and modified starch |
| 07/27/2006 | US20060168682 Plant peptide with antimicrobial activity |
| 07/27/2006 | US20060168672 B7-like molecules and uses thereof |
| 07/27/2006 | US20060168666 Autoimmune disease model animal |
| 07/27/2006 | US20060167232 Antibody against n-terminal peptide or c-terminal peptide of gpc3 solubilized in blood |
| 07/27/2006 | US20060167231 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/27/2006 | US20060167230 Anti-pci neutralizing antibody |
| 07/27/2006 | US20060167225 Novel fluorescent protein from aequorea coerulscens and methods for using the same |
| 07/27/2006 | US20060166912 Use of cytochrome p450 enzyme cyp2w1 as a drug target for cancer theraphy |
| 07/27/2006 | US20060166889 Chimeric peptides that facilitate the transport of insulin across biological membranes that have a first domain having a specific translocation sequence and a second domain having at least a biologically active portion of an insulin polypeptide; treatment of diabetes |
| 07/27/2006 | US20060166325 Glial cell line-derived neurotrophic factor receptor |
| 07/27/2006 | US20060166316 Phosphodiesterase 10a7 isoforms and methods of use |
| 07/27/2006 | US20060166310 Serotonin receptor |
| 07/27/2006 | US20060166309 Novel G-protein coupled receptors |
| 07/27/2006 | US20060166297 solid phase; antitumor agents |
| 07/27/2006 | US20060166295 Method for determination of likelihood of occurrence of preterm labor in pregnant females |
| 07/27/2006 | US20060166294 Apoptosis marker antibodies and methods of use |
| 07/27/2006 | US20060166291 KID31 and antibodies that bind thereto |
| 07/27/2006 | US20060166290 Primary central nervous system tumor specific BEHAB isoforms |
| 07/27/2006 | US20060166287 Method for Identifying compounds for suppressing metastasizing tumor cells |
| 07/27/2006 | US20060166284 used to form a non-thrombogenic coating on the surface of a medical device; antibodies bind with greater affinity to the factor VIIa/tissue factor (FVIIa/TF) complex than to tissue factor (TF) alone |
| 07/27/2006 | US20060166283 Means for detecting neurodegenerative processes and applications of same |
| 07/27/2006 | US20060166259 APM1 biallelic markers and uses thereof |
| 07/27/2006 | US20060166256 IL-1 receptor accessory protein |
| 07/27/2006 | US20060166252 Novel methods of constructing libraries of genetic packages that collectively display the members of a diverse family of peptides, polypeptides or proteins |
| 07/27/2006 | US20060166225 Methods and compositions for polypeptide engineering |
| 07/27/2006 | US20060166214 Marker for detecting mesenchymal stem cell and method of distinguishing mesenchymal stem cell using the marker |
| 07/27/2006 | US20060166213 Novel compositions and methods in cancer |
| 07/27/2006 | US20060166212 Breast specific protein expressed in cancer and methods of use thereof |
| 07/27/2006 | US20060166211 Ss 1,3-n-acetyl-d-galactosamine transferase protein, nucleic acid encoding the same and method of examining canceration using the same |
| 07/27/2006 | US20060166209 Growth hormone variations in humans and its uses |
| 07/27/2006 | US20060166193 Binding protein |
| 07/27/2006 | US20060166188 Methods of examining swine genetic resistance to rna virus-origin disease |
| 07/27/2006 | US20060166186 Detecting a compartment or a macromolecule of a cell by expressing a polynucleotide encoding chimeric polypeptide in the cell having single chain Fv region that binds a detectable molecule and a S-AKAP84 region that binds the macromolecule or targets the compartment; exposing cell to molecule; analyzing |
| 07/27/2006 | US20060165728 Campylobacter glycans and glycopeptides |
| 07/27/2006 | US20060165706 Antibodies against CTLA4 and uses therefor |
| 07/27/2006 | US20060165705 Immunoselective targeting agents and methods of use thereof |
| 07/27/2006 | US20060165704 Methods for the treatment of an infectious bacterial disease with an anti-lactone or lactone derived signal molecules antibody |
| 07/27/2006 | US20060165703 Methods and compositions useful for inhibition of alpha v beta 5 mediated angiogenesis |
| 07/27/2006 | US20060165701 Agents for the diagnosis and treatment of tumors that expose alerted proteins on the cell surface |
| 07/27/2006 | US20060165699 Use of specified tcf target genes to identify drugs for the treatment of cancer in particular colorectal cancer in which tcf/ss-cateini/wnt signalling plays a central role |
| 07/27/2006 | US20060165698 Polypeptide from ink of molluscs; L-lysine or L-arginine oxidase capable of producing hydrogen peroxide in tumor tissues with less toxic side effects upon normal cells |
| 07/27/2006 | US20060165697 comprising a homeopathically potentised form of polyclonal, antibodies to endothelial nitric oxide synthase (NO synthase) |
| 07/27/2006 | US20060165696 Remedy for spinal injury containing interleukin-6 antagonist |
| 07/27/2006 | US20060165695 Antibody against human insulin-like growth factor |
| 07/27/2006 | US20060165694 Fab fragments and their DNA sequences used for preparation of complete recombinant Anti-Rhesus D antibodies; biodrugs; medical diagnosis |
| 07/27/2006 | US20060165693 treating a patient having cancer |
| 07/27/2006 | US20060165692 Humanized anti-CD3 specific antibodies |
| 07/27/2006 | US20060165691 Humanized anti-CD3 specific antibodies |
| 07/27/2006 | US20060165690 Vaccine comprising an antigen conjugated to low valency anti-cd40 or anti-cd28 antibodies |
| 07/27/2006 | US20060165689 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7 |
| 07/27/2006 | US20060165688 Remedies for pemphigus containing cd40l antogonist as the active ingredient |